Redeye updates its Base Case and forecasts for Lime following the Q2 report.
Redeye provides its initial take on Lifco’s Q2 2025 report, which came in below our estimates.
Q2 results Organic growth improved and was positive y-o-y, but earnings in service-related units wei...
Q2e: FX headwinds, but continued strong margins We expect Nolato to report Q2 net sales of SEK 2,345...
The organic CER growth at -11% is a major negative surprise, and the H1 organic CER growth is 1%.
- Sales -1%, adj. EBIT -2.7m vs. ABGSCe - EBIT lower on higher than expected opex - Recycling contin...
- Q2 sales 8% below our ests. at SEK 202m, for -9% org.
- Q2: Sales 6% above, EBITDA NOK 7m vs ABGSCe NOK 3m - Positive development in projects - Only minor...
Redeye updates its view on Nanologica following the Q2 report.
Incap has guided for net sales to grow by 0-20% for 2025.
- We cut '25e-'27e adj. EBITA by 5-4% - Pressure on demand and hourly prices - NTM EV/EBITA below 7x...
'25e-'27e adj. EBIT down 8-2% Incident in Spain weighs on near-term momentum Trading at NTM EV/EBITA...
- Occupancy improvement in Q2 - Management open for more accretion - 2025e P/CEPS at 14x, ~12.
Prisma Properties, noterat i juni 2024, fokuserar på externa handelsplatser i trafiknära lägen med i...
The company posted a trading statement in late June.
